TrialJournal of neurology2020

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.

Mark S Freedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.